Psyence Group Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div yield, %

—

Shrs. gr., 5y

-21.88%

Rev. gr., 5y

Revenues

Net income

-587k

L+46.69%

CFO

-975k

L-82.43%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Psyence Group, Inc. is a life science biotechnology company, which engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness. Its divisions include Psyence Production and Psyence Therapeutics. The company was founded by Jody Aufrichtig on March 26, 1994 and is headquartered in Toronto, Canada.

Key people

Jody Aufrichtig

Executive Chairman of the Board · since 2021

Adri Botha

Interim Chief Financial Officer · since 2024

Warwick Corden-Lloyd

Director · since 2024

Alan Friedman

Independent Director · since 2023

URL

https://psyence.com/

IPO date

Jan 27, 2021

Employees

Domiciled in

Incorporated in

Headquarters & legal address

121 Richmond Street West
Toronto, ON M5H 2K1
CA

Valuation

Order:

Title in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title in thousands, except ratios and share amounts	2026‑03	2025‑03	2024‑03	2023‑03	2022‑03	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT